Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
Authors
Keywords
Hsp90, IPI-504, Glioma, Stem cells, Anti-tumor activity
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 120, Issue 3, Pages 473-481
Publisher
Springer Nature
Online
2014-08-12
DOI
10.1007/s11060-014-1579-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor-Initiating Cells
- (2013) J. Fu et al. CANCER RESEARCH
- Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis
- (2013) Daniela A. Bota et al. JOURNAL OF NEUROSURGERY
- High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer
- (2013) Jiahong Wang et al. PLoS One
- Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
- (2012) Stephen T. Keir et al. Anti-Cancer Agents in Medicinal Chemistry
- TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth
- (2012) K Di et al. ONCOGENE
- Regulation of Embryonic Stem Cell Pluripotency by Heat Shock Protein 90
- (2012) Eric Bradley et al. STEM CELLS
- Heat shock protein 90 inhibition: rationale and clinical potential
- (2012) Robert B. Den et al. Therapeutic Advances in Medical Oncology
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
- (2011) M. Scaltriti et al. MOLECULAR CANCER THERAPEUTICS
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
- (2011) X. Gong et al. NEUROLOGY
- The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78
- (2010) G. Roue et al. BLOOD
- The Pathobiology of Glioma Tumors
- (2009) Candece L. Gladson et al. Annual Review of Pathology-Mechanisms of Disease
- Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
- (2008) Dongweon Song et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
- (2008) Claire Marie-Elisabeth Sauvageot et al. NEURO-ONCOLOGY
- 17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis
- (2008) Markus David Siegelin et al. NEUROBIOLOGY OF DISEASE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High-Grade Glioma
- (2008) Francesca Pistollato et al. STEM CELLS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started